Literature DB >> 16502202

Cytokine and growth factor mRNA expression patterns associated with the hypercontracted, hyperpigmented healing phenotype of red duroc pigs: a model of abnormal human scar development?

Corrie L Gallant-Behm1, Merle E Olson, David A Hart.   

Abstract

BACKGROUND: Skin wounds in red Duroc pigs heal with the formation of hypercontractile, hyperpigmented scars, similar in some respects to human hypertrophic scars.
OBJECTIVE: The goal of this study was to characterize the mRNA expression patterns for a subset of relevant cytokines, growth factors, receptors, and transcription factors involved in the red Duroc scarring phenotype.
METHODS: Full-thickness and deep dermal wounds were created on the backs of juvenile female red Duroc pigs. Samples were taken every two weeks postwounding and total RNA and DNA were extracted and quantified. RT-PCR was performed using porcine gene-specific primers for 15 relevant molecules.
RESULTS: The majority of molecules examined exhibited a biphasic pattern of expression, with peaks of expression at days 14 and 56 postinjury.
CONCLUSIONS: The molecular expression pattern observed correlates well with the gross healing phenotype and matrix molecule expression patterns previously reported in red Duroc pigs. These findings enhance our understanding of the processes associated with fibroproliferative scar-formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16502202     DOI: 10.1007/s10227-005-0105-4

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  9 in total

1.  Connexin 43 regulates the expression of wound healing-related genes in human gingival and skin fibroblasts.

Authors:  Rana Tarzemany; Guoqiao Jiang; Jean X Jiang; Corrie Gallant-Behm; Colin Wiebe; David A Hart; Hannu Larjava; Lari Häkkinen
Journal:  Exp Cell Res       Date:  2018-03-27       Impact factor: 3.905

2.  Expression of collagen genes in the cones of skin in the Duroc/Yorkshire porcine model of fibroproliferative scarring.

Authors:  Kathy Q Zhu; Gretchen J Carrougher; Oliver P Couture; Christopher K Tuggle; Nicole S Gibran; Loren H Engrav
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

Review 3.  Review of the female Duroc/Yorkshire pig model of human fibroproliferative scarring.

Authors:  Kathy Q Zhu; Gretchen J Carrougher; Nicole S Gibran; F Frank Isik; Loren H Engrav
Journal:  Wound Repair Regen       Date:  2007 Sep-Oct       Impact factor: 3.617

4.  Expression of integrin alphavbeta6 and TGF-beta in scarless vs scar-forming wound healing.

Authors:  Ameneh Eslami; Corrie L Gallant-Behm; David A Hart; Colin Wiebe; Dariush Honardoust; Humphrey Gardner; Lari Häkkinen; Hannu S Larjava
Journal:  J Histochem Cytochem       Date:  2009-02-16       Impact factor: 2.479

5.  A multimodal assessment of melanin and melanocyte activity in abnormally pigmented hypertrophic scar.

Authors:  Taryn E Travis; Pejhman Ghassemi; Jessica C Ramella-Roman; Nicholas J Prindeze; Dereck W Paul; Lauren T Moffatt; Marion H Jordan; Jeffrey W Shupp
Journal:  J Burn Care Res       Date:  2015 Jan-Feb       Impact factor: 1.845

6.  Functional genomics unique to week 20 post wounding in the deep cone/fat dome of the Duroc/Yorkshire porcine model of fibroproliferative scarring.

Authors:  Loren H Engrav; Christopher K Tuggle; Kathleen F Kerr; Kathy Q Zhu; Surawej Numhom; Oliver P Couture; Richard P Beyer; Anne M Hocking; Gretchen J Carrougher; Maria Luiza C Ramos; Matthew B Klein; Nicole S Gibran
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

7.  Models of abnormal scarring.

Authors:  Bommie F Seo; Jun Yong Lee; Sung-No Jung
Journal:  Biomed Res Int       Date:  2013-09-03       Impact factor: 3.411

8.  Does the appearance of the cutaneous scar after cesarean section reflect the residual myometrial thickness?

Authors:  Ammar Al Naimi; Niki Mouzakiti; Carmen Eißmann; Frank Louwen; Franz Bahlmann
Journal:  Arch Gynecol Obstet       Date:  2021-01-07       Impact factor: 2.344

Review 9.  Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?

Authors:  David A Hart
Journal:  Int J Inflam       Date:  2015-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.